SARS-CoV-2-Queries

clinicalTrials.rq

Code examples: curl

SPARQL

SELECT ?trial ?trialLabel ?intervention ?interventionLabel ?phase ?phaseLabel ?identifier WHERE {
  VALUES ?topic {
    wd:Q84263196 wd:Q82069695
  }
  ?trial wdt:P31 wd:Q30612 ;
         wdt:P921 ?topic ;
         wdt:P6099 ?phase ;
         wdt:P3098 ?identifier .
  OPTIONAL {
    ?trial wdt:P4844 ?intervention .
  }
  SERVICE wikibase:label { bd:serviceParam wikibase:language "en,en". }
} ORDER BY DESC(?identifier) ASC(?intervention)

run or edit

Output

trial intervention phase identifier
A Randomised, Controlled, Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Adjuvanted Recombinant Protein SARS-COV-2 Vaccine in Healthy Adult Subjects (edit) COVAX-19 (edit) phase I clinical trial (edit) NCT04453852
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04434248
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04434248
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 (edit) chloroquine (edit) phase II clinical trial (edit) NCT04434248
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 (edit) chloroquine (edit) phase III clinical trial (edit) NCT04434248
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 (edit) lopinavir (edit) phase II clinical trial (edit) NCT04434248
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 (edit) lopinavir (edit) phase III clinical trial (edit) NCT04434248
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 (edit) ritonavir (edit) phase II clinical trial (edit) NCT04434248
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 (edit) ritonavir (edit) phase III clinical trial (edit) NCT04434248
Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older (edit) mRNA-1273 (edit) phase II clinical trial (edit) NCT04405076
Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) (edit) phase II clinical trial (edit) NCT04380519
Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) (edit) phase III clinical trial (edit) NCT04380519
Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults (edit) tozinameran (edit) phase I clinical trial (edit) NCT04368728
Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults (edit) tozinameran (edit) phase II clinical trial (edit) NCT04368728
Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults (edit) tozinameran (edit) phase III clinical trial (edit) NCT04368728
Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity (edit) budesonide (edit) phase III clinical trial (edit) NCT04361474
COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1 (edit) nivolumab (edit) phase II clinical trial (edit) NCT04356508
Interferon Beta 1a in Hospitalized COVID-19 Patients (edit) interferon (edit) phase IV clinical trial (edit) NCT04350671
Interferon Beta 1a in Hospitalized COVID-19 Patients (edit) interferon beta-1a (edit) phase IV clinical trial (edit) NCT04350671
Interferon Beta 1a in Hospitalized COVID-19 Patients (edit) hydroxychloroquine (edit) phase IV clinical trial (edit) NCT04350671
Interferon Beta 1a in Hospitalized COVID-19 Patients (edit) lopinavir (edit) phase IV clinical trial (edit) NCT04350671
Interferon Beta 1a in Hospitalized COVID-19 Patients (edit) ritonavir (edit) phase IV clinical trial (edit) NCT04350671
Treatment of SARS Caused by COVID-19 With Ruxolitinib (edit) ruxolitinib (edit) phase I clinical trial (edit) NCT04334044
Treatment of SARS Caused by COVID-19 With Ruxolitinib (edit) ruxolitinib (edit) phase II clinical trial (edit) NCT04334044
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection (edit) chloroquine (edit) phase II clinical trial (edit) NCT04333914
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection (edit) chloroquine (edit) phase II clinical trial (edit) NCT04333914
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase II clinical trial (edit) NCT04333914
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase II clinical trial (edit) NCT04333914
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection (edit) nivolumab (edit) phase II clinical trial (edit) NCT04333914
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection (edit) nivolumab (edit) phase II clinical trial (edit) NCT04333914
CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04333732
CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION (edit) chloroquine (edit) phase II clinical trial (edit) NCT04333732
CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase II clinical trial (edit) NCT04333732
Hydroxychloroquine in Outpatient Adults With COVID-19 (edit) hydroxychloroquine (edit) phase I clinical trial (edit) NCT04333654
Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 (edit) chloroquine (edit) phase II clinical trial (edit) NCT04333628
Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 (edit) chloroquine (edit) phase III clinical trial (edit) NCT04333628
Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase II clinical trial (edit) NCT04333628
Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase III clinical trial (edit) NCT04333628
Application of Desferal to Treat COVID-19 (edit) deferoxamine (edit) phase I clinical trial (edit) NCT04333550
Application of Desferal to Treat COVID-19 (edit) deferoxamine (edit) phase II clinical trial (edit) NCT04333550
Piclidenoson for Treatment of COVID-19 (edit) piclidenoson (edit) phase II clinical trial (edit) NCT04333472
OPEN LABEL, RANDOMIZED PHASE II/III STUDY OF IFX-1 IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA (edit) phase II clinical trial (edit) NCT04333420
OPEN LABEL, RANDOMIZED PHASE II/III STUDY OF IFX-1 IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA (edit) phase III clinical trial (edit) NCT04333420
Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS (edit) phase I clinical trial (edit) NCT04333368
Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS (edit) phase II clinical trial (edit) NCT04333368
Safety in Convalescent Plasma Transfusion to COVID-19 (edit) phase I clinical trial (edit) NCT04333355
Study Testing Convalescent Plasma vs Best Supportive Care (edit) phase I clinical trial (edit) NCT04333251
Study Testing Convalescent Plasma vs Best Supportive Care (edit) phase I clinical trial (edit) NCT04333251
Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04333225
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04332991
Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04332835
Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04332835
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial (edit) ACE inhibitor (edit) phase II clinical trial (edit) NCT04332666
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial (edit) ACE inhibitor (edit) phase III clinical trial (edit) NCT04332666
Convalescent Plasma for Patients With COVID-19: A Pilot Study (edit) phase II clinical trial (edit) NCT04332380
Azithromycin for COVID-19 Treatment in Outpatients Nationwide (edit) azithromycin (edit) phase III clinical trial (edit) NCT04332107
Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 (edit) azithromycin (edit) phase II clinical trial (edit) NCT04332094
Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 (edit) azithromycin (edit) phase II clinical trial (edit) NCT04332094
Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04332094
Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04332094
Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 (edit) tocilizumab (edit) phase II clinical trial (edit) NCT04332094
Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 (edit) tocilizumab (edit) phase II clinical trial (edit) NCT04332094
Mild COVID-19 Peginterferon Lambda (edit) phase II clinical trial (edit) NCT04331899
Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04331834
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Tocilizumab Trial - CORIMUNO-19 - TOCI (CORIMUNO-TOCI) (edit) tocilizumab (edit) phase II clinical trial (edit) NCT04331808
Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis (edit) tocilizumab (edit) phase II clinical trial (edit) NCT04331795
Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS (edit) phase I clinical trial (edit) NCT04331613
Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS (edit) phase II clinical trial (edit) NCT04331613
ChloroQUine As antiviRal treAtmeNT In coroNavirus infEction 2020 (edit) chloroquine (edit) phase IV clinical trial (edit) NCT04331600
ChloroQUine As antiviRal treAtmeNT In coroNavirus infEction 2020 (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase IV clinical trial (edit) NCT04331600
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) formoterol fumarate (edit) phase II clinical trial (edit) NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) formoterol fumarate (edit) phase III clinical trial (edit) NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) levamisole (edit) phase II clinical trial (edit) NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) levamisole (edit) phase III clinical trial (edit) NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) budesonide (edit) phase II clinical trial (edit) NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) budesonide (edit) phase III clinical trial (edit) NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) chloroquine (edit) phase II clinical trial (edit) NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) chloroquine (edit) phase III clinical trial (edit) NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) lopinavir (edit) phase II clinical trial (edit) NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) lopinavir (edit) phase III clinical trial (edit) NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) ritonavir (edit) phase II clinical trial (edit) NCT04331470
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (edit) ritonavir (edit) phase III clinical trial (edit) NCT04331470
Protective Role of Inhaled Steroids for Covid-19 Infection (edit) budesonide (edit) phase III clinical trial (edit) NCT04331054
Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial (edit) lopinavir (edit) phase II clinical trial (edit) NCT04330690
Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial (edit) ritonavir (edit) phase II clinical trial (edit) NCT04330690
Treatment of COVID-19 Patients With Anti-interleukin Drugs (edit) Siltuximab (edit) phase IV clinical trial (edit) NCT04330638
Treatment of COVID-19 Patients With Anti-interleukin Drugs (edit) anakinra (edit) phase IV clinical trial (edit) NCT04330638
A Trial of Ciclesonide in Adults With Mild COVID-19 (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04330586
A Trial of Ciclesonide in Adults With Mild COVID-19 (edit) Ciclesonide (edit) phase II clinical trial (edit) NCT04330586
Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection (edit) Janus kinase inhibitors (edit) phase IV clinical trial (edit) NCT04330495
Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection (edit) hydroxychloroquine (edit) phase IV clinical trial (edit) NCT04330495
Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial) (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04330144
The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04329923
Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04329832
Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia (edit) prednisolone (edit) phase II clinical trial (edit) NCT04329650
Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia (edit) methylprednisolone acetate (edit) phase II clinical trial (edit) NCT04329650
Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia (edit) prednisolone acetate (edit) phase II clinical trial (edit) NCT04329650
Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia (edit) methylprednisolone hemisuccinate (edit) phase II clinical trial (edit) NCT04329650
Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia (edit) prednisolone 21-phosphate (edit) phase II clinical trial (edit) NCT04329650
Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia (edit) prednisolone hemisuccinate (edit) phase II clinical trial (edit) NCT04329650
Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia (edit) Siltuximab (edit) phase II clinical trial (edit) NCT04329650
Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia (edit) methylprednisolone (edit) phase II clinical trial (edit) NCT04329650
Hydroxychloroquine to Prevent Covid19 Pneumonia (ALBERTA HOPE-Covid19) (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04329611
Hydroxychloroquine to Prevent Covid19 Pneumonia (ALBERTA HOPE-Covid19) (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04329611
Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19 (edit) hydroxychloroquine (edit) phase I clinical trial (edit) NCT04329572
Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19 (edit) hydroxychloroquine (edit) phase I clinical trial (edit) NCT04329572
EPICOS Clinical Trial for the Prevention of Infection in Healthcare Personnel (edit) tenofovir (edit) phase III clinical trial (edit) NCT04329520
EPICOS Clinical Trial for the Prevention of Infection in Healthcare Personnel (edit) tenofovir (edit) phase III clinical trial (edit) NCT04329520
EPICOS Clinical Trial for the Prevention of Infection in Healthcare Personnel (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04329520
EPICOS Clinical Trial for the Prevention of Infection in Healthcare Personnel (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04329520
EPICOS Clinical Trial for the Prevention of Infection in Healthcare Personnel (edit) emtricitabine (edit) phase III clinical trial (edit) NCT04329520
EPICOS Clinical Trial for the Prevention of Infection in Healthcare Personnel (edit) emtricitabine (edit) phase III clinical trial (edit) NCT04329520
ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemia (edit) ACE inhibitor (edit) phase III clinical trial (edit) NCT04329195
Hydroxychloroquine for COVID-19 PEP (edit) DL-ascorbic acid (edit) phase I clinical trial (edit) NCT04328961
Hydroxychloroquine for COVID-19 PEP (edit) DL-ascorbic acid (edit) phase I clinical trial (edit) NCT04328961
Hydroxychloroquine for COVID-19 PEP (edit) hydroxychloroquine (edit) phase I clinical trial (edit) NCT04328961
Hydroxychloroquine for COVID-19 PEP (edit) hydroxychloroquine (edit) phase I clinical trial (edit) NCT04328961
The Vietnam Chloroquine Treatment on COVID-19 (edit) chloroquine (edit) phase II clinical trial (edit) NCT04328493
The Vietnam Chloroquine Treatment on COVID-19 (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase II clinical trial (edit) NCT04328493
REDUCING HEALTH CARE WORKERS ABSENTEEISM IN SARS-CoV-2 PANDEMIC THROUGH BACILLUS CALMETTE-GUÉRIN VACCINATION, A RANDOMIZED CONTROLLED TRIAL (edit) BCG vaccine (edit) phase III clinical trial (edit) NCT04328441
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04328285
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04328285
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers (edit) lopinavir (edit) phase III clinical trial (edit) NCT04328285
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers (edit) lopinavir (edit) phase III clinical trial (edit) NCT04328285
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers (edit) ritonavir (edit) phase III clinical trial (edit) NCT04328285
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers (edit) ritonavir (edit) phase III clinical trial (edit) NCT04328285
Effectiveness of Hydroxychloroquine in Covid-19 Patients (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04328272
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) coal tar pitch volatiles (edit) phase II clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) coal tar pitch volatiles (edit) phase III clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) coal tar pitch volatiles (edit) phase II clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) coal tar pitch volatiles (edit) phase III clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) losartan (edit) phase II clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) losartan (edit) phase III clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) losartan (edit) phase II clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) losartan (edit) phase III clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) lopinavir (edit) phase II clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) lopinavir (edit) phase III clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) lopinavir (edit) phase II clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) lopinavir (edit) phase III clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) ritonavir (edit) phase II clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) ritonavir (edit) phase III clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) ritonavir (edit) phase II clinical trial (edit) NCT04328012
Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial) (edit) ritonavir (edit) phase III clinical trial (edit) NCT04328012
Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 (edit) phase II clinical trial (edit) NCT04327505
Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 (edit) phase III clinical trial (edit) NCT04327505
COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III (edit) dexamethasone acetate (edit) phase III clinical trial (edit) NCT04327401
COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III (edit) cyclophosphamide (edit) phase III clinical trial (edit) NCT04327401
Sarilumab COVID-19 (edit) phase II clinical trial (edit) NCT04327388
Sarilumab COVID-19 (edit) phase III clinical trial (edit) NCT04327388
BCG Vaccination to Protect Healthcare Workers Against COVID-19 (edit) BCG vaccine (edit) phase III clinical trial (edit) NCT04327206
Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) (edit) Sargramostim (edit) phase IV clinical trial (edit) NCT04326920
The GReek Study in the Effects of Colchicine in Covid-19 (edit) gloriosine (edit) phase IV clinical trial (edit) NCT04326790
COVIDL1: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection (edit) phase III clinical trial (edit) NCT04326426
Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection (edit) phase I clinical trial (edit) NCT04326036
Hydroxychloroquine Versus Placebo in Patients Presenting COVID-19 Infection and at Risk of Secondary Complication: a Prospective, Multicentre, Randomised, Double-blind Study (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04325893
Convalescent Plasma to Limit Coronavirus Associated Complications (edit) phase II clinical trial (edit) NCT04325672
Convalescent Plasma to Limit Coronavirus Associated Complications (edit) phase II clinical trial (edit) NCT04325672
Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection (edit) naproxen (edit) phase III clinical trial (edit) NCT04325633
Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 (edit) dexamethasone acetate (edit) phase IV clinical trial (edit) NCT04325061
Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 (edit) cyclophosphamide (edit) phase IV clinical trial (edit) NCT04325061
A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 (edit) Sargramostim (edit) phase I clinical trial (edit) NCT04324996
A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 (edit) Sargramostim (edit) phase II clinical trial (edit) NCT04324996
A Study of a Candidate COVID-19 Vaccine (COV001) (edit) AZD1222 (edit) phase I clinical trial (edit) NCT04324606
A Study of a Candidate COVID-19 Vaccine (COV001) (edit) AZD1222 (edit) phase II clinical trial (edit) NCT04324606
Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial (edit) chloroquine (edit) phase III clinical trial (edit) NCT04324463
Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase III clinical trial (edit) NCT04324463
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI (edit) phase II clinical trial (edit) NCT04324073
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI (edit) phase III clinical trial (edit) NCT04324073
Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. (edit) anakinra (edit) phase II clinical trial (edit) NCT04324021
Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. (edit) anakinra (edit) phase III clinical trial (edit) NCT04324021
Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19 (edit) phase II clinical trial (edit) NCT04323800
Efficacy and Safety Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 Non-immune Plasma) Among Adults Exposed to COVID-19 (edit) phase II clinical trial (edit) NCT04323800
Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death (edit) hydroxychloroquine (edit) phase I clinical trial (edit) NCT04323631
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) prednisolone (edit) phase II clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) prednisolone (edit) phase III clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) methylprednisolone acetate (edit) phase II clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) methylprednisolone acetate (edit) phase III clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) prednisolone acetate (edit) phase II clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) prednisolone acetate (edit) phase III clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) methylprednisolone hemisuccinate (edit) phase II clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) methylprednisolone hemisuccinate (edit) phase III clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) prednisolone 21-phosphate (edit) phase II clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) prednisolone 21-phosphate (edit) phase III clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) prednisolone hemisuccinate (edit) phase II clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) prednisolone hemisuccinate (edit) phase III clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) methylprednisolone (edit) phase II clinical trial (edit) NCT04323592
Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome (edit) methylprednisolone (edit) phase III clinical trial (edit) NCT04323592
Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04323345
Traditional Chinese Medicine for Severe COVID-19 (edit) phase III clinical trial (edit) NCT04323332
Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19 (edit) non-steroidal anti-inflammatory drug (edit) phase IV clinical trial (edit) NCT04323228
Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure (edit) phase II clinical trial (edit) NCT04322773
Colchicine Coronavirus SARS-CoV2 Trial (edit) (S)-(−)-colchicine (edit) phase III clinical trial (edit) NCT04322682
Colchicine Efficacy in COVID-19 Pneumonia (edit) gloriosine (edit) phase II clinical trial (edit) NCT04322565
Proactive Prophylaxis With Azithromycin and Chloroquine in Hospitalized Patients With COVID-19 (edit) hydroxychloroquine (edit) phase IV clinical trial (edit) NCT04322396
Proactive Prophylaxis With Azithromycin and Chloroquine in Hospitalized Patients With COVID-19 (edit) chloroquine (edit) phase IV clinical trial (edit) NCT04322396
Proactive Prophylaxis With Azithromycin and Chloroquine in Hospitalized Patients With COVID-19 (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase IV clinical trial (edit) NCT04322396
Escin in Patients With Covid-19 Infection (edit) phase II clinical trial (edit) NCT04322344
Escin in Patients With Covid-19 Infection (edit) phase III clinical trial (edit) NCT04322344
Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04322123
Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients (edit) Janus kinase inhibitors (edit) phase II clinical trial (edit) NCT04321993
Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04321993
Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients (edit) lopinavir (edit) phase II clinical trial (edit) NCT04321993
Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients (edit) ritonavir (edit) phase II clinical trial (edit) NCT04321993
The Efficacy of Different Anti-viral Drugs in (Severe Acute Respiratory Syndrome-Corona Virus-2) SARS-CoV-2 (edit) antiviral agent (edit) phase II clinical trial (edit) NCT04321616
The Efficacy of Different Anti-viral Drugs in (Severe Acute Respiratory Syndrome-Corona Virus-2) SARS-CoV-2 (edit) antiviral agent (edit) phase III clinical trial (edit) NCT04321616
The Efficacy of Different Anti-viral Drugs in (Severe Acute Respiratory Syndrome-Corona Virus-2) SARS-CoV-2 (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04321616
The Efficacy of Different Anti-viral Drugs in (Severe Acute Respiratory Syndrome-Corona Virus-2) SARS-CoV-2 (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04321616
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04321278
COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir (edit) lopinavir (edit) phase III clinical trial (edit) NCT04321174
COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir (edit) ritonavir (edit) phase III clinical trial (edit) NCT04321174
The Impact of Camostat Mesilate on COVID-19 Infection (edit) gabexate (edit) phase I clinical trial (edit) NCT04321096
The Impact of Camostat Mesilate on COVID-19 Infection (edit) gabexate (edit) phase II clinical trial (edit) NCT04321096
A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia (edit) phase III clinical trial (edit) NCT04320615
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study. (edit) antiviral agent (edit) phase III clinical trial (edit) NCT04320277
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study. (edit) ritonavir (edit) phase III clinical trial (edit) NCT04320277
Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff (edit) interferon (edit) phase III clinical trial (edit) NCT04320238
Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff (edit) thymalfasin (edit) phase III clinical trial (edit) NCT04320238
A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure (edit) phase I clinical trial (edit) NCT04319731
Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04318444
Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04318444
Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04318015
Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) (edit) tocilizumab (edit) phase II clinical trial (edit) NCT04317092
CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment (edit) phase III clinical trial (edit) NCT04317040
Norwegian Coronavirus Disease 2019 Study (edit) hydroxychloroquine (edit) phase IV clinical trial (edit) NCT04316377
Norwegian Coronavirus Disease 2019 Study (edit) chloroquine (edit) phase IV clinical trial (edit) NCT04316377
Norwegian Coronavirus Disease 2019 Study (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase IV clinical trial (edit) NCT04316377
NestCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia (edit) phase I clinical trial (edit) NCT04315987
Trial of Treatments for COVID-19 in Hospitalized Adults (edit) interferon (edit) phase III clinical trial (edit) NCT04315948
Trial of Treatments for COVID-19 in Hospitalized Adults (edit) interferon beta-1a (edit) phase III clinical trial (edit) NCT04315948
Trial of Treatments for COVID-19 in Hospitalized Adults (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04315948
Trial of Treatments for COVID-19 in Hospitalized Adults (edit) lopinavir (edit) phase III clinical trial (edit) NCT04315948
Trial of Treatments for COVID-19 in Hospitalized Adults (edit) ritonavir (edit) phase III clinical trial (edit) NCT04315948
Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) (edit) hydroxychloroquine (edit) phase III clinical trial (edit) NCT04315896
Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 (edit) phase II clinical trial (edit) NCT04315298
Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 (edit) phase III clinical trial (edit) NCT04315298
Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells (edit) phase I clinical trial (edit) NCT04313322
The Use PUL-042 Inhalation Solution to Prevent COVID-19 in Adults Exposed to SARS-CoV-2 (edit) paracetamol (edit) phase II clinical trial (edit) NCT04313023
The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection (edit) paracetamol (edit) phase II clinical trial (edit) NCT04312997
The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection (edit) paracetamol (edit) phase II clinical trial (edit) NCT04312997
NO Prevention of COVID-19 for Healthcare Providers (edit) nitric oxide (radical) (edit) phase II clinical trial (edit) NCT04312243
Randomized Controlled Trial of Losartan for Patients With COVID-19 Requiring Hospitalization (edit) losartan (edit) phase II clinical trial (edit) NCT04312009
Intravenous Aviptadil for COVID-19 Associated Acute Respiratory Distress (edit) phentolamine (edit) phase II clinical trial (edit) NCT04311697
Randomized Controlled Trial of Losartan for Patients With COVID-19 Not Requiring Hospitalization (edit) losartan (edit) phase II clinical trial (edit) NCT04311177
Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 (edit) phase II clinical trial (edit) NCT04310865
Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 (edit) phase III clinical trial (edit) NCT04310865
Tetrandrine Tablets Used in the Treatment of COVID-19 (edit) phase IV clinical trial (edit) NCT04308317
Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) (edit) hydroxychloroquine (edit) phase II clinical trial (edit) NCT04307693
Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) (edit) lopinavir (edit) phase II clinical trial (edit) NCT04307693
Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) (edit) ritonavir (edit) phase II clinical trial (edit) NCT04307693
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (edit) nitric oxide (radical) (edit) phase II clinical trial (edit) NCT04305457
A Pilot Study of Sildenafil in COVID-19 (edit) citric acid (edit) phase III clinical trial (edit) NCT04304313
A Pilot Study of Sildenafil in COVID-19 (edit) sildenafil citrate (edit) phase III clinical trial (edit) NCT04304313
A Pilot Study of Sildenafil in COVID-19 (edit) trisodium citrate (edit) phase III clinical trial (edit) NCT04304313
Treatment of Mild Cases and Chemoprophylaxis of Contacts as Prevention of the COVID-19 Epidemic (edit) antiviral agent (edit) phase III clinical trial (edit) NCT04304053
Treatment of Mild Cases and Chemoprophylaxis of Contacts as Prevention of the COVID-19 Epidemic (edit) chloroquine (edit) phase III clinical trial (edit) NCT04304053
Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquin for Treatment of COVID19 : A Randomized Control Trial (edit) oseltamivir (edit) phase III clinical trial (edit) NCT04303299
Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquin for Treatment of COVID19 : A Randomized Control Trial (edit) darunavir (edit) phase III clinical trial (edit) NCT04303299
Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquin for Treatment of COVID19 : A Randomized Control Trial (edit) chloroquine (edit) phase III clinical trial (edit) NCT04303299
Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquin for Treatment of COVID19 : A Randomized Control Trial (edit) lopinavir (edit) phase III clinical trial (edit) NCT04303299
Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquin for Treatment of COVID19 : A Randomized Control Trial (edit) ritonavir (edit) phase III clinical trial (edit) NCT04303299
Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquin for Treatment of COVID19 : A Randomized Control Trial (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase III clinical trial (edit) NCT04303299
Safety and Immunity of Covid-19 aAPC Vaccine (edit) phase I clinical trial (edit) NCT04299724
Stem Cell Educator Therapy Treat the Viral Inflammation Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (edit) phase II clinical trial (edit) NCT04299152
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) (edit) remdesivir (edit) phase III clinical trial (edit) NCT04292899
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) (edit) COVID-19 (edit) phase III clinical trial (edit) NCT04292899
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment (edit) remdesivir (edit) phase III clinical trial (edit) NCT04292730
The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19 (edit) phase II clinical trial (edit) NCT04291053
The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19 (edit) phase III clinical trial (edit) NCT04291053
Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19. (edit) nitric oxide (radical) (edit) phase II clinical trial (edit) NCT04290871
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection (edit) nitric oxide (radical) (edit) phase II clinical trial (edit) NCT04290858
Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19) (edit) COVID-19 (edit) phase I clinical trial (edit) NCT04288102
Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19) (edit) COVID-19 (edit) phase II clinical trial (edit) NCT04288102
The Clinical Study of Carrimycin on Treatment Patients With COVID-19 (edit) chloroquine (edit) phase IV clinical trial (edit) NCT04286503
The Clinical Study of Carrimycin on Treatment Patients With COVID-19 (edit) lopinavir (edit) phase IV clinical trial (edit) NCT04286503
The Clinical Study of Carrimycin on Treatment Patients With COVID-19 (edit) ritonavir (edit) phase IV clinical trial (edit) NCT04286503
The Clinical Study of Carrimycin on Treatment Patients With COVID-19 (edit) Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites (edit) phase IV clinical trial (edit) NCT04286503
Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection (edit) mRNA-1273 (edit) phase I clinical trial (edit) NCT04283461
Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection (edit) mRNA-1273 (edit) phase I clinical trial (edit) NCT04283461
Adaptive COVID-19 Treatment Trial (edit) phase II clinical trial (edit) NCT04280705
Fingolimod in COVID-19 (edit) fingolimod hydrochloride (edit) phase II clinical trial (edit) NCT04280588
Fingolimod in COVID-19 (edit) COVID-19 (edit) phase II clinical trial (edit) NCT04280588
Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19 (edit) COVID-19 (edit) phase II clinical trial (edit) NCT04278963
Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19 (edit) COVID-19 (edit) phase III clinical trial (edit) NCT04278963
Function and Safety Study of SARS-CoV-2 Synthetic Minigene Vaccines (edit) phase I clinical trial (edit) NCT04276896
Function and Safety Study of SARS-CoV-2 Synthetic Minigene Vaccines (edit) phase II clinical trial (edit) NCT04276896
Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia (edit) bevacizumab (edit) phase II clinical trial (edit) NCT04275414
Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia (edit) bevacizumab (edit) phase III clinical trial (edit) NCT04275414
The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19 (edit) thalidomide (edit) phase II clinical trial (edit) NCT04273581
The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19 (edit) COVID-19 (edit) phase II clinical trial (edit) NCT04273581
The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia (edit) thalidomide (edit) phase II clinical trial (edit) NCT04273529
Immunoregulatory Therapy for 2019-nCoV (edit) immunoglobulin (edit) phase II clinical trial (edit) NCT04268537
Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia (edit) DL-ascorbic acid (edit) phase II clinical trial (edit) NCT04264533

Code examples

curl

curl -s https://raw.githubusercontent.com/egonw/SARS-CoV-2-Queries/master/sparql/clinicalTrials.rq | sed 's+<lang/>+en+' > clinicalTrials.rq

curl -H "Accept: text/tab-separated-values" -G https://query.wikidata.org/bigdata/namespace/wdq/sparql --data-urlencode query@clinicalTrials.rq

This SPARQL query is available under CCZero.